Ireland Research And Markets released a report detailing the rapid growth of the hepatitis B virus vaccine market, which is expected to grow at a Compound Annual Growth Rate of 5.33% during the analysis period.
"The leading driving factor for the global hepatitis B (HBV) vaccine market is the rising number of cases of this viral infection in infants. Chronic HBV infections in infants are difficult to handle, and often fatal. The perinatal transmission of HBV is now standing as a public health issue of great importance," according to Cision's PR Newswire article. The World Health Organization (WHO) suggests that all pregnant women get tested for HBV and that any HBV-positive mothers have their infants vaccinated promptly after birth.
According to the US Department of Health and Human Services website, hepatitis B is a virus that causes the infection and inflammation of the liver. This can impair the ability of the liver to function and have detrimental effects. This virus can be transmitted when blood, semen, or some other bodily fluid from one person who is infected with HBV enters the body of someone who is not infected. Either through sexual contact, sharing needles, syringes, or other drug-injection equipment, or from mother to baby at birth, the hepatitis B virus can be shared. There is no cure for a hepatitis B infection, however, there are available vaccines.
Research and Markets identifies themselves on their online About Us page as "the world’s largest market research store". Founded in 2002 and headquartered next to the Guinness Brewery in Dublin, Ireland they provide data and insight for over 450 clients covering 800 different industries.